Finding skin and blood markers to predict treatment response in chronic inflammatory skin diseases

Researchers are trying to understand why people with chronic inflammatory skin diseases respond so differently to treatment. This study will collect skin samples and blood samples from people with conditions like atopic dermatitis, psoriasis, and lupus, as well as from healthy volunteers, to identify biological markers (measurable signs in the body) that can predict whether a particular treatment will work for a specific patient.

Currently, doctors have difficulty predicting which patients will respond well to which treatments, and treatment outcomes vary widely even among people with the same diagnosis. By identifying biological markers now, doctors may be able to personalize treatment plans in the future and develop new, more effective therapies for these challenging skin diseases.